Curocell (XKRX:372320) Operating Cash Flow per Share : ₩ (TTM As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Curocell Operating Cash Flow per Share?

Curocell's operating cash flow per share for the six months ended in Jun. 2023 was ₩-1,078.91. Curocell does not have enough years/quarters to calculate the operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2023.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -20.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Curocell's Operating Cash Flow per Share or its related term are showing as below:

XKRX:372320' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -20.9 Med: 8.95 Max: 38.8
Current: -20.9

During the past 5 years, Curocell's highest 3-Year average Operating Cash Flow per Share Growth Rate was 38.80% per year. The lowest was -20.90% per year. And the median was 8.95% per year.

XKRX:372320's 3-Year OCF Growth Rate is ranked worse than
75.51% of 1237 companies
in the Biotechnology industry
Industry Median: 3.3 vs XKRX:372320: -20.90

Curocell Operating Cash Flow per Share Historical Data

The historical data trend for Curocell's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Operating Cash Flow per Share Chart

Curocell Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

-6,702.92

-1,208.15

-1,370.09

-1,533.34

-2,134.69

Curocell Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	-844.95	-688.74	-1,078.91	-1,117.32

Competitive Comparison of Curocell's Operating Cash Flow per Share

For the Biotechnology subindustry, Curocell's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curocell's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curocell's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Curocell's Price-to-Operating-Cash-Flow falls into.

Curocell Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Curocell's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-25264.01	/	11.835
	=	-2,134.69

Curocell's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Jun. 2023 )	=	Cash Flow from Operations (Q: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2023 )
	=	-12040.588	/	11.160
	=	-1,078.91

Curocell Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Curocell's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Curocell (XKRX:372320) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002

Website

https://www.curocellbtx.com

Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines